For example, overexpression of RGS1 inhibited CXCL12-mediated human plasmacytoma cell migration, and epigenetic inhibition of RGS2 has been associated with prostate cancer progression and overexpression of RGS5 on lung cancer cells (He et al., 2019). Here, RGS5 is linked to prostate carcinoma.